Relvar® Ellipta® Inhalers
The supply of Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (30 dose) and Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (30 dose) to NHS Scotland.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£838,000
Published
28 Aug 2019
Closes
28 Aug 2019
Procurement details
Source
Pcs
Region
Scotland
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Relvar® Ellipta® Inhalers
£838,000
The supply of Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (30 dose) and Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (30 dose) to NHS Scotland.
Delivery: United Kingdom
Documents
Unlock document linkSupply of Relvar® Ellipta® Inhalers
Not provided
The supply of Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (30 dose) and Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (30 dose) to NHS Scotland.
Award notice · Web page
Relvar® Ellipta® Inhalers
Not provided
The supply of Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (30 dose) and Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (30 dose) to NHS Scotland.
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.